Protagenic Therapeutics Warrant
PTIXW
PTIXW
4 hedge funds and large institutions have $6.76K invested in Protagenic Therapeutics Warrant in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.41K | |
| 2 | -$1.28K | |
| 3 | -$202 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $4.77K |
|
|||
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.45K |
|
|||
|
TSS
3
Two Sigma Securities
New York
| $536 |
|
|||
4
Bank of America
Charlotte,
North Carolina
| $5 |
|
|||
|
WAM
5
Warberg Asset Management
Winnetka,
Illinois
| – |
|
|||
|
GS
6
GTS Securities
New York
| – |
|
|||
|
7
UBS Group
Zurich,
Switzerland
| – |
|